Monjuvi (Tafasitamab-cxix): Understanding Its Side Effects and Management

Understanding Monjuvi (Tafasitamab-cxix) and Its Side Effects Monjuvi, with the active ingredient tafasitamab-cxix, is a significant immunotherapy drug used in the treatment of a specific type of blood cancer known as diffuse large B-cell lymphoma (DLBCL). It is particularly prescribed for adults whose DLBCL has either returned after previous treatments or has not responded to other therapies, and who are not candidates for a stem cell transplant. Monjuvi is typically administered in combination with another medication called lenalidomide. This combination therapy is a crucial option for patients facing challenging circumstances in their fight against DLBCL. The drug is presented as a powder that is reconstituted into a solution and given as an intravenous (IV) infusion, meaning it is injected into a vein over a period of time by a healthcare professional. The name includes "-cxix" to distinguish it from any similar medications that might be developed in the future. Treatment Regimen The treatment course often involves taking the combination of Monjuvi and lenalidomide for up to 12 cycles. Following this initial phase, doctors usually recommend continuing with Monjuvi alone. The duration and specifics of the treatment plan are tailored to each individual patient's condition and response. Common Side Effects of Monjuvi While Monjuvi offers a vital treatment option, it is important for patients to be aware of potential side effects. Not everyone will experience these, but they are important to monitor. Some of the more commonly reported side effects in clinical studies include: Diarrhea Cough Fever Mild Side Effects and Their Management Monjuvi can also cause milder side effects, which may not be as severe but can still impact a patient's quality of life. These include: Swelling in the hands, fingers, legs, or feet (edema) Infections, such as those affecting the lungs or urinary tract Mild allergic reactions It's important to note that while an allergic reaction is possible with Monjuvi, it was not specifically reported in the initial studies. However, any signs of an allergic reaction should be taken seriously. In many cases, these milder side effects may resolve on their own between treatment sessions. Sometimes, they can be effectively managed through strategies such as a slower infusion rate or adjustments to the dosage. If any of these symptoms become persistent or bothersome, it is crucial to consult with your doctor or pharmacist. Do not stop Monjuvi treatment unless specifically advised by your doctor. Serious Side Effects Requiring Immediate Medical Attention While less common, Monjuvi can also lead to serious side effects that require prompt medical intervention. Fatal adverse reactions have been reported in a small percentage of patients, including: Cerebrovascular accident (stroke): Occurred in approximately 1.2% of patients. Progressive multifocal leukoencephalopathy (PML): Also occurred in about 1.2% of patients. PML is a rare, serious brain infection. Other serious side effects that have been reported include: Severe allergic reactions: Symptoms can include swelling of the face, lips, tongue, or throat, and difficulty breathing. These are life-threatening and require immediate emergency medical care. Low blood cell counts (cytopenias): This can increase the risk of infections and bleeding. Liver problems: Signs may include yellowing of the skin or eyes (jaundice), dark urine, or abdominal pain. Tumor Lysis Syndrome (TLS): A condition where cancer cells release their contents into the bloodstream, which can lead to kidney failure, heart rhythm problems, and seizures. Managing Fatigue and Recovery One common concern after cancer treatment is fatigue. Recovery from Monjuvi treatment is a personal journey, and the time it takes can vary. Low energy levels can persist for approximately 90 to 120 days after treatment completion. This is because the bone marrow needs time to replenish its supply of red and white blood cells to normal levels, a process essential for restoring energy and fighting off infections. Important Precautions and When to Consult a Doctor It is vital to discuss all your medical conditions, allergies, and current medications with your doctor before starting Monjuvi. Inform them about any history of heart, lung, kidney, or liver disease, as well as any infections. When to seek immediate medical help: If you experience symptoms of a severe allergic reaction, such as swelling or difficulty breathing, call 911 or your local emergency number immediately. If you develop serious side effects like signs of stroke (sudden numbness or weakness, confusion, trouble speaking, vision problems, severe headache), symptoms of PML, or signs of liver problems, contact your doctor right away. If you experience symptoms that feel like a medical emergency at any point during or after treatment, call 911 or your local emergency number. Other important considerations: Breastfeeding: Breastfeeding is not considered safe during Monjuvi treatment and for up to 3 months after finishing the therapy. Discuss safe alternatives with your doctor if you are breastfeeding or planning to do so. Pregnancy: Monjuvi can harm a developing fetus. If you are pregnant or plan to become pregnant, talk to your doctor about the risks and necessary precautions. Both men and women receiving Monjuvi should use effective contraception during treatment and for a specified period afterward. Conclusion Monjuvi is a powerful tool in the fight against DLBCL, offering hope to patients who may have limited treatment options. Understanding its potential side effects, both common and serious, is crucial for effective management and patient safety. Open communication with your healthcare team about any symptoms or concerns is paramount throughout the treatment journey. By staying informed and vigilant, patients can work closely with their

In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.